Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium

The retrospective cohort study involved 50 patients with Telogen Effluvium (TE), a temporary hair loss condition, who were treated with adipocyte-derived mesenchymal stem cells-conditioned media (ADSC-CM) for five months. The treatment resulted in a significant increase in hair density, thickness, and number of follicular hair units, with a response rate between 70% and 92%. The study found that the effectiveness of ADSC-CM was not influenced by the patient's age or type of TE. Despite its limitations, such as the lack of a control group and small cohort size, the study concludes that ADSC-CM is a promising new treatment strategy for TE. Further large-scale randomized controlled trials are recommended to confirm these findings.